# Investigating Targetable Metabolic Pathways Sustaining Pancreatic Cancer

> **NCT05296421** · NA · RECRUITING · sponsor: **Rutgers, The State University of New Jersey** · enrollment: 16 (estimated)

## Conditions studied

- Pancreatic Ductal Adenocarcinoma

## Interventions

- **PROCEDURE:** Biopsy
- **PROCEDURE:** Therapeutic Conventional Surgery
- **OTHER:** Uniformly-labeled [13C]glucose

## Key facts

- **NCT ID:** NCT05296421
- **Lead sponsor:** Rutgers, The State University of New Jersey
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-03-14
- **Primary completion:** 2027-03-01
- **Final completion:** 2027-07-01
- **Target enrollment:** 16 (ESTIMATED)
- **Last updated:** 2026-05-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05296421

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05296421, "Investigating Targetable Metabolic Pathways Sustaining Pancreatic Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05296421. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*